Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer

28 Dec 2020

Abstract excerpt

The clinical significance and underlying molecular mechanism of miRNA-222-3p in metastatic prostate cancer (MPCa) remain unclear. The present study used a large number of cases (n = 1,502) based on miRNA chip and miRNA sequencing datasets to evaluate the expression and diagnostic potential of miRNA-222-3p in MPCa. We applied a variety of meta-analytic methods, including forest maps, sensitivity analysis, subgroup...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Molecular Biology Techniques and Applications
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33356818
DOI: 10.1080/21655979.2020.1867405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancerPMID 33356818Read ↗

Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.Semantic proximity Read ↗

Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genesSemantic proximity Read ↗

Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis modelSemantic proximity Read ↗

Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone MetastasisSemantic proximity Read ↗

Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression ProfilesSemantic proximity Read ↗

MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA SequencingSemantic proximity Read ↗

Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancerSemantic proximity Read ↗

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancerSemantic proximity Read ↗

miR-455-3p in peripheral blood is a potentially superior diagnostic marker for prostate cancer to PSASemantic proximity Read ↗

lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axisSemantic proximity Read ↗

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancerSemantic proximity Read ↗

Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.